Please Wait.....
Report
Long Read Sequencing Market By Application (Research Applications, Clinical Applications), By Technique (Single-Molecule Real-Time (SMRT) Sequencing, Nanopore Sequencing, Synthetic Long Read Sequencing), By Product (Instruments, Consumables, Services), By End User (Academic and Government Research Institutes, Pharmaceutical and Biotech Companies, Hospitals and Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
Market Report I 2024-03-01 I 395 Pages I Allied Market Research
The long read sequencing market was valued at $724.43 million in 2022 and is estimated to reach $5,163.41 million by 2032, exhibiting a CAGR of 21.7% from 2023 to 2032. Long read sequencing is a genomic technique that reads longer stretches of DNA compared to traditional methods. It employs innovative technologies like single-molecule sequencing to generate DNA sequences spanning thousands to millions of base pairs. Platforms such as Pacific Biosciences and Oxford Nanopore Technologies utilize techniques such as nanopore sequencing to achieve extended read lengths. Long read sequencing facilitates comprehensive analysis of complex genomic regions, repetitive sequences, and structural variations. Its applications include de novo genome assembly, resolving complex genomic structures, understanding genetic diseases, and exploring microbial diversity. Overall, long read sequencing revolutionizes genomic research by providing detailed and accurate genomic information.
The rise in the prevalence of genetic disorders and cancer is indeed a significant driver for the increased demand for long read sequencing technologies. Genetic disorders and cancer are inherently complex diseases influenced by multiple genetic factors, including mutations, structural variations, and genomic rearrangements. Long read sequencing offers the ability to comprehensively analyze the entire genome, enabling researchers and clinicians to identify rare and novel genetic variants associated with these diseases more accurately. For instance, the World Health Organization (WHO) estimated that approximately 400,000 children develop cancer every year worldwide, emphasizing the urgent need for advanced genomic technologies to better understand the genetic basis of cancer and develop targeted therapies. By providing insights into the underlying genetic mechanisms of disease, long read sequencing plays a crucial role in advancing precision medicine initiatives and improving clinical outcomes for patients with genetic disorders and cancer.
In addition, with the decreasing cost of sequencing and increasing awareness of the importance of genomics in various domains, there's a growing demand for comprehensive genomic insights. Long read sequencing provides a deeper understanding of genomic structure and function, allowing researchers to uncover complex genetic variations and better understand the genetic basis of diseases, traits, and evolutionary processes. Thus, the rise in genetic and cancer disorders and the wide application of long read sequencing in the disease diagnosis is potentially diving the market growth.
However, the lack of skilled professionals in the field of long read sequencing is expected to hinder market growth. Operating and interpreting data from long read sequencing platforms require specialized expertise in molecular biology, bioinformatics, and genomics. The shortage of adequately trained personnel may limit the adoption and utilization of long read sequencing technologies, delaying their implementation in research, clinical diagnostics, and industrial applications.
The long read sequencing market is segmented on the basis of application, technique, product, end user, and region. By application, it is bifurcated into research application and clinical application. By technique, the market is categorized into single-molecule real-time sequencing (SMRT), nanopore sequencing and synthetic long read sequencing. On the basis of product, it is segmented into instruments, consumables, and services. The instrument segment is further classified into system and software. By end user, it is segregated into academic and government research institutes, pharmaceutical and biotechnological companies, hospitals and clinics, and others. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major key players that operate in the global long read sequencing market are Agilent Technologies, Inc. BaseClear BV, Cantata Bio, FG Technologies,Grandomics,MicrobesNG, Novogene co., ltd., Oxford Nanopore Technologies, Pacific Biosciences Inc., CD Genomics,Danaher Corporation, BGI Genomics,St Vincent's Hospital Australia, Takara Holdings Inc., Thermo Fisher Scientific, Inc., Element Biosciences, and Illumina, Inc. Key players operating in the market have adopted product launch, acquisition, partnership and collaboration as their key strategy to expand their product portfolio.
Key Benefits for Stakeholders
-
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the long read sequencing market analysis from 2022 to 2032 to identify the prevailing long read sequencing market opportunities.
-
The market research is offered along with information related to key drivers, restraints, and opportunities.
-
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
-
In-depth analysis of the long read sequencing market segmentation assists to determine the prevailing market opportunities.
-
Major countries in each region are mapped according to their revenue contribution to the global market.
-
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
-
The report includes the analysis of the regional as well as global long read sequencing market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Application
- Research Applications
- Clinical Applications
By Technique
- Nanopore Sequencing
- Synthetic Long Read Sequencing
- Single-Molecule Real-Time (SMRT) Sequencing
By Product
- Instruments
- Type
- System
- Software
- Consumables
- Services
By End User
- Academic and Government Research Institutes
- Pharmaceutical and Biotech Companies
- Hospitals and Clinics
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- Cantata Bio
- Illumina, Inc.
- Danaher Corporation
- Element Biosciences
- FG Technologies
- MicrobesNG
- Oxford Nanopore Technologies plc.
- CD Genomics
- BGI Genomics
- St Vincents Hospital Melbourne
- Agilent Technologies, Inc.
- TAKARA HOLDINGS INC.
- BaseClear B.V.
- GrandOmics
- Novogene co., ltd.
- PacBio
- Thermo Fisher Scientific Inc.
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter's five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Moderate threat of new entrants
3.3.3. Moderate threat of substitutes
3.3.4. Moderate intensity of rivalry
3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in demand for precision medicine
3.4.1.2. Rise in number of partnership and collaboration
3.4.1.3. The growing initiatives taken by the key players for drug discovery
3.4.2. Restraints
3.4.2.1. High Initial Investment and Cost
3.4.3. Opportunities
3.4.3.1. Rise in technological advancements
CHAPTER 4: LONG READ SEQUENCING MARKET, BY APPLICATION
4.1. Overview
4.1.1. Market size and forecast
4.2. Research Applications
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Clinical Applications
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
CHAPTER 5: LONG READ SEQUENCING MARKET, BY TECHNIQUE
5.1. Overview
5.1.1. Market size and forecast
5.2. Single-Molecule Real-Time (SMRT) Sequencing
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Nanopore Sequencing
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Synthetic Long Read Sequencing
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
CHAPTER 6: LONG READ SEQUENCING MARKET, BY PRODUCT
6.1. Overview
6.1.1. Market size and forecast
6.2. Instruments
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.2.4. Instruments Long Read Sequencing Market by Type
6.3. Consumables
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Services
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: LONG READ SEQUENCING MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Academic and Government Research Institutes
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Pharmaceutical and Biotech Companies
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Hospitals and Clinics
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country
7.5. Others
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by region
7.5.3. Market share analysis by country
CHAPTER 8: LONG READ SEQUENCING MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast By Region
8.2. North America
8.2.1. Key market trends, growth factors and opportunities
8.2.2. Market size and forecast, by Application
8.2.3. Market size and forecast, by Technique
8.2.4. Market size and forecast, by Product
8.2.5. Market size and forecast, by End User
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. Market size and forecast, by Application
8.2.6.1.2. Market size and forecast, by Technique
8.2.6.1.3. Market size and forecast, by Product
8.2.6.1.4. Market size and forecast, by End User
8.2.6.2. Canada
8.2.6.2.1. Market size and forecast, by Application
8.2.6.2.2. Market size and forecast, by Technique
8.2.6.2.3. Market size and forecast, by Product
8.2.6.2.4. Market size and forecast, by End User
8.2.6.3. Mexico
8.2.6.3.1. Market size and forecast, by Application
8.2.6.3.2. Market size and forecast, by Technique
8.2.6.3.3. Market size and forecast, by Product
8.2.6.3.4. Market size and forecast, by End User
8.3. Europe
8.3.1. Key market trends, growth factors and opportunities
8.3.2. Market size and forecast, by Application
8.3.3. Market size and forecast, by Technique
8.3.4. Market size and forecast, by Product
8.3.5. Market size and forecast, by End User
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Market size and forecast, by Application
8.3.6.1.2. Market size and forecast, by Technique
8.3.6.1.3. Market size and forecast, by Product
8.3.6.1.4. Market size and forecast, by End User
8.3.6.2. France
8.3.6.2.1. Market size and forecast, by Application
8.3.6.2.2. Market size and forecast, by Technique
8.3.6.2.3. Market size and forecast, by Product
8.3.6.2.4. Market size and forecast, by End User
8.3.6.3. UK
8.3.6.3.1. Market size and forecast, by Application
8.3.6.3.2. Market size and forecast, by Technique
8.3.6.3.3. Market size and forecast, by Product
8.3.6.3.4. Market size and forecast, by End User
8.3.6.4. Italy
8.3.6.4.1. Market size and forecast, by Application
8.3.6.4.2. Market size and forecast, by Technique
8.3.6.4.3. Market size and forecast, by Product
8.3.6.4.4. Market size and forecast, by End User
8.3.6.5. Spain
8.3.6.5.1. Market size and forecast, by Application
8.3.6.5.2. Market size and forecast, by Technique
8.3.6.5.3. Market size and forecast, by Product
8.3.6.5.4. Market size and forecast, by End User
8.3.6.6. Rest of Europe
8.3.6.6.1. Market size and forecast, by Application
8.3.6.6.2. Market size and forecast, by Technique
8.3.6.6.3. Market size and forecast, by Product
8.3.6.6.4. Market size and forecast, by End User
8.4. Asia-Pacific
8.4.1. Key market trends, growth factors and opportunities
8.4.2. Market size and forecast, by Application
8.4.3. Market size and forecast, by Technique
8.4.4. Market size and forecast, by Product
8.4.5. Market size and forecast, by End User
8.4.6. Market size and forecast, by country
8.4.6.1. Japan
8.4.6.1.1. Market size and forecast, by Application
8.4.6.1.2. Market size and forecast, by Technique
8.4.6.1.3. Market size and forecast, by Product
8.4.6.1.4. Market size and forecast, by End User
8.4.6.2. China
8.4.6.2.1. Market size and forecast, by Application
8.4.6.2.2. Market size and forecast, by Technique
8.4.6.2.3. Market size and forecast, by Product
8.4.6.2.4. Market size and forecast, by End User
8.4.6.3. India
8.4.6.3.1. Market size and forecast, by Application
8.4.6.3.2. Market size and forecast, by Technique
8.4.6.3.3. Market size and forecast, by Product
8.4.6.3.4. Market size and forecast, by End User
8.4.6.4. Australia
8.4.6.4.1. Market size and forecast, by Application
8.4.6.4.2. Market size and forecast, by Technique
8.4.6.4.3. Market size and forecast, by Product
8.4.6.4.4. Market size and forecast, by End User
8.4.6.5. South Korea
8.4.6.5.1. Market size and forecast, by Application
8.4.6.5.2. Market size and forecast, by Technique
8.4.6.5.3. Market size and forecast, by Product
8.4.6.5.4. Market size and forecast, by End User
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Market size and forecast, by Application
8.4.6.6.2. Market size and forecast, by Technique
8.4.6.6.3. Market size and forecast, by Product
8.4.6.6.4. Market size and forecast, by End User
8.5. LAMEA
8.5.1. Key market trends, growth factors and opportunities
8.5.2. Market size and forecast, by Application
8.5.3. Market size and forecast, by Technique
8.5.4. Market size and forecast, by Product
8.5.5. Market size and forecast, by End User
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Market size and forecast, by Application
8.5.6.1.2. Market size and forecast, by Technique
8.5.6.1.3. Market size and forecast, by Product
8.5.6.1.4. Market size and forecast, by End User
8.5.6.2. Saudi Arabia
8.5.6.2.1. Market size and forecast, by Application
8.5.6.2.2. Market size and forecast, by Technique
8.5.6.2.3. Market size and forecast, by Product
8.5.6.2.4. Market size and forecast, by End User
8.5.6.3. South Africa
8.5.6.3.1. Market size and forecast, by Application
8.5.6.3.2. Market size and forecast, by Technique
8.5.6.3.3. Market size and forecast, by Product
8.5.6.3.4. Market size and forecast, by End User
8.5.6.4. Rest of LAMEA
8.5.6.4.1. Market size and forecast, by Application
8.5.6.4.2. Market size and forecast, by Technique
8.5.6.4.3. Market size and forecast, by Product
8.5.6.4.4. Market size and forecast, by End User
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product mapping of top 10 player
9.4. Competitive dashboard
9.5. Competitive heatmap
9.6. Top player positioning, 2022
CHAPTER 10: COMPANY PROFILES
10.1. Agilent Technologies, Inc.
10.1.1. Company overview
10.1.2. Key executives
10.1.3. Company snapshot
10.1.4. Operating business segments
10.1.5. Product portfolio
10.1.6. Business performance
10.2. BaseClear B.V.
10.2.1. Company overview
10.2.2. Key executives
10.2.3. Company snapshot
10.2.4. Operating business segments
10.2.5. Product portfolio
10.3. Cantata Bio
10.3.1. Company overview
10.3.2. Key executives
10.3.3. Company snapshot
10.3.4. Operating business segments
10.3.5. Product portfolio
10.3.6. Key strategic moves and developments
10.4. Element Biosciences
10.4.1. Company overview
10.4.2. Key executives
10.4.3. Company snapshot
10.4.4. Operating business segments
10.4.5. Product portfolio
10.4.6. Key strategic moves and developments
10.5. FG Technologies
10.5.1. Company overview
10.5.2. Key executives
10.5.3. Company snapshot
10.5.4. Operating business segments
10.5.5. Product portfolio
10.6. GrandOmics
10.6.1. Company overview
10.6.2. Key executives
10.6.3. Company snapshot
10.6.4. Operating business segments
10.6.5. Product portfolio
10.6.6. Key strategic moves and developments
10.7. Illumina, Inc.
10.7.1. Company overview
10.7.2. Key executives
10.7.3. Company snapshot
10.7.4. Operating business segments
10.7.5. Product portfolio
10.7.6. Business performance
10.7.7. Key strategic moves and developments
10.8. MicrobesNG
10.8.1. Company overview
10.8.2. Key executives
10.8.3. Company snapshot
10.8.4. Operating business segments
10.8.5. Product portfolio
10.9. Novogene co., ltd.
10.9.1. Company overview
10.9.2. Key executives
10.9.3. Company snapshot
10.9.4. Operating business segments
10.9.5. Product portfolio
10.9.6. Key strategic moves and developments
10.10. Oxford Nanopore Technologies plc.
10.10.1. Company overview
10.10.2. Key executives
10.10.3. Company snapshot
10.10.4. Operating business segments
10.10.5. Product portfolio
10.10.6. Key strategic moves and developments
10.11. PacBio
10.11.1. Company overview
10.11.2. Key executives
10.11.3. Company snapshot
10.11.4. Operating business segments
10.11.5. Product portfolio
10.11.6. Business performance
10.11.7. Key strategic moves and developments
10.12. St Vincents Hospital Melbourne
10.12.1. Company overview
10.12.2. Key executives
10.12.3. Company snapshot
10.12.4. Operating business segments
10.12.5. Product portfolio
10.13. TAKARA HOLDINGS INC.
10.13.1. Company overview
10.13.2. Key executives
10.13.3. Company snapshot
10.13.4. Operating business segments
10.13.5. Product portfolio
10.13.6. Business performance
10.14. Thermo Fisher Scientific Inc.
10.14.1. Company overview
10.14.2. Key executives
10.14.3. Company snapshot
10.14.4. Operating business segments
10.14.5. Product portfolio
10.14.6. Business performance
10.15. Danaher Corporation
10.15.1. Company overview
10.15.2. Key executives
10.15.3. Company snapshot
10.15.4. Operating business segments
10.15.5. Product portfolio
10.15.6. Business performance
10.16. BGI Genomics
10.16.1. Company overview
10.16.2. Key executives
10.16.3. Company snapshot
10.16.4. Operating business segments
10.16.5. Product portfolio
10.17. CD Genomics
10.17.1. Company overview
10.17.2. Key executives
10.17.3. Company snapshot
10.17.4. Operating business segments
10.17.5. Product portfolio
LIST OF TABLES
TABLE 01. GLOBAL LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 02. LONG READ SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022-2032 ($MILLION)
TABLE 03. LONG READ SEQUENCING MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022-2032 ($MILLION)
TABLE 04. GLOBAL LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 05. LONG READ SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME (SMRT) SEQUENCING, BY REGION, 2022-2032 ($MILLION)
TABLE 06. LONG READ SEQUENCING MARKET FOR NANOPORE SEQUENCING, BY REGION, 2022-2032 ($MILLION)
TABLE 07. LONG READ SEQUENCING MARKET FOR SYNTHETIC LONG READ SEQUENCING, BY REGION, 2022-2032 ($MILLION)
TABLE 08. GLOBAL LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 09. LONG READ SEQUENCING MARKET FOR INSTRUMENTS, BY REGION, 2022-2032 ($MILLION)
TABLE 10. GLOBAL INSTRUMENTS LONG READ SEQUENCING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 11. LONG READ SEQUENCING MARKET FOR CONSUMABLES, BY REGION, 2022-2032 ($MILLION)
TABLE 12. LONG READ SEQUENCING MARKET FOR SERVICES, BY REGION, 2022-2032 ($MILLION)
TABLE 13. GLOBAL LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 14. LONG READ SEQUENCING MARKET FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2022-2032 ($MILLION)
TABLE 15. LONG READ SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECH COMPANIES, BY REGION, 2022-2032 ($MILLION)
TABLE 16. LONG READ SEQUENCING MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2022-2032 ($MILLION)
TABLE 17. LONG READ SEQUENCING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 18. LONG READ SEQUENCING MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 19. NORTH AMERICA LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 20. NORTH AMERICA LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 21. NORTH AMERICA LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 22. NORTH AMERICA LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 23. NORTH AMERICA LONG READ SEQUENCING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 24. U.S. LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 25. U.S. LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 26. U.S. LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 27. U.S. LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 28. CANADA LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 29. CANADA LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 30. CANADA LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 31. CANADA LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 32. MEXICO LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 33. MEXICO LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 34. MEXICO LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 35. MEXICO LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 36. EUROPE LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 37. EUROPE LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 38. EUROPE LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 39. EUROPE LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 40. EUROPE LONG READ SEQUENCING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 41. GERMANY LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 42. GERMANY LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 43. GERMANY LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 44. GERMANY LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 45. FRANCE LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 46. FRANCE LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 47. FRANCE LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 48. FRANCE LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 49. UK LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 50. UK LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 51. UK LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 52. UK LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 53. ITALY LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 54. ITALY LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 55. ITALY LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 56. ITALY LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 57. SPAIN LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 58. SPAIN LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 59. SPAIN LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 60. SPAIN LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 61. REST OF EUROPE LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 62. REST OF EUROPE LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 63. REST OF EUROPE LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 64. REST OF EUROPE LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 65. ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 66. ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 67. ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 68. ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 69. ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 70. JAPAN LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 71. JAPAN LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 72. JAPAN LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 73. JAPAN LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 74. CHINA LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 75. CHINA LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 76. CHINA LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 77. CHINA LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 78. INDIA LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 79. INDIA LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 80. INDIA LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 81. INDIA LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 82. AUSTRALIA LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 83. AUSTRALIA LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 84. AUSTRALIA LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 85. AUSTRALIA LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 86. SOUTH KOREA LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 87. SOUTH KOREA LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 88. SOUTH KOREA LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 89. SOUTH KOREA LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 90. REST OF ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 91. REST OF ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 92. REST OF ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 93. REST OF ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 94. LAMEA LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 95. LAMEA LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 96. LAMEA LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 97. LAMEA LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 98. LAMEA LONG READ SEQUENCING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 99. BRAZIL LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 100. BRAZIL LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 101. BRAZIL LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 102. BRAZIL LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 103. SAUDI ARABIA LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 104. SAUDI ARABIA LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 105. SAUDI ARABIA LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 106. SAUDI ARABIA LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 107. SOUTH AFRICA LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 108. SOUTH AFRICA LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 109. SOUTH AFRICA LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 110. SOUTH AFRICA LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 111. REST OF LAMEA LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 112. REST OF LAMEA LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 113. REST OF LAMEA LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 114. REST OF LAMEA LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 115. AGILENT TECHNOLOGIES, INC.: KEY EXECUTIVES
TABLE 116. AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
TABLE 117. AGILENT TECHNOLOGIES, INC.: PRODUCT SEGMENTS
TABLE 118. AGILENT TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
TABLE 119. BASECLEAR B.V.: KEY EXECUTIVES
TABLE 120. BASECLEAR B.V.: COMPANY SNAPSHOT
TABLE 121. BASECLEAR B.V.: SERVICE SEGMENTS
TABLE 122. BASECLEAR B.V.: PRODUCT PORTFOLIO
TABLE 123. CANTATA BIO: KEY EXECUTIVES
TABLE 124. CANTATA BIO: COMPANY SNAPSHOT
TABLE 125. CANTATA BIO: PRODUCT SEGMENTS
TABLE 126. CANTATA BIO: SERVICE SEGMENTS
TABLE 127. CANTATA BIO: PRODUCT PORTFOLIO
TABLE 128. CANTATA BIO: KEY STRATERGIES
TABLE 129. ELEMENT BIOSCIENCES: KEY EXECUTIVES
TABLE 130. ELEMENT BIOSCIENCES: COMPANY SNAPSHOT
TABLE 131. ELEMENT BIOSCIENCES: PRODUCT SEGMENTS
TABLE 132. ELEMENT BIOSCIENCES: PRODUCT PORTFOLIO
TABLE 133. ELEMENT BIOSCIENCES: KEY STRATERGIES
TABLE 134. FG TECHNOLOGIES: KEY EXECUTIVES
TABLE 135. FG TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 136. FG TECHNOLOGIES: PRODUCT SEGMENTS
TABLE 137. FG TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 138. GRANDOMICS: KEY EXECUTIVES
TABLE 139. GRANDOMICS: COMPANY SNAPSHOT
TABLE 140. GRANDOMICS: PRODUCT SEGMENTS
TABLE 141. GRANDOMICS: PRODUCT PORTFOLIO
TABLE 142. GRANDOMICS: KEY STRATERGIES
TABLE 143. ILLUMINA, INC.: KEY EXECUTIVES
TABLE 144. ILLUMINA, INC.: COMPANY SNAPSHOT
TABLE 145. ILLUMINA, INC.: PRODUCT SEGMENTS
TABLE 146. ILLUMINA, INC.: PRODUCT PORTFOLIO
TABLE 147. ILLUMINA, INC.: KEY STRATERGIES
TABLE 148. MICROBESNG: KEY EXECUTIVES
TABLE 149. MICROBESNG: COMPANY SNAPSHOT
TABLE 150. MICROBESNG: PRODUCT SEGMENTS
TABLE 151. MICROBESNG: PRODUCT PORTFOLIO
TABLE 152. NOVOGENE CO., LTD.: KEY EXECUTIVES
TABLE 153. NOVOGENE CO., LTD.: COMPANY SNAPSHOT
TABLE 154. NOVOGENE CO., LTD.: SERVICE SEGMENTS
TABLE 155. NOVOGENE CO., LTD.: PRODUCT PORTFOLIO
TABLE 156. NOVOGENE CO., LTD.: KEY STRATERGIES
TABLE 157. OXFORD NANOPORE TECHNOLOGIES PLC.: KEY EXECUTIVES
TABLE 158. OXFORD NANOPORE TECHNOLOGIES PLC.: COMPANY SNAPSHOT
TABLE 159. OXFORD NANOPORE TECHNOLOGIES PLC.: PRODUCT SEGMENTS
TABLE 160. OXFORD NANOPORE TECHNOLOGIES PLC.: PRODUCT PORTFOLIO
TABLE 161. OXFORD NANOPORE TECHNOLOGIES PLC.: KEY STRATERGIES
TABLE 162. PACBIO: KEY EXECUTIVES
TABLE 163. PACBIO: COMPANY SNAPSHOT
TABLE 164. PACBIO: PRODUCT SEGMENTS
TABLE 165. PACBIO: PRODUCT PORTFOLIO
TABLE 166. PACBIO: KEY STRATERGIES
TABLE 167. ST VINCENTS HOSPITAL MELBOURNE: KEY EXECUTIVES
TABLE 168. ST VINCENTS HOSPITAL MELBOURNE: COMPANY SNAPSHOT
TABLE 169. ST VINCENTS HOSPITAL MELBOURNE: PRODUCT SEGMENTS
TABLE 170. ST VINCENTS HOSPITAL MELBOURNE: PRODUCT PORTFOLIO
TABLE 171. TAKARA HOLDINGS INC.: KEY EXECUTIVES
TABLE 172. TAKARA HOLDINGS INC.: COMPANY SNAPSHOT
TABLE 173. TAKARA HOLDINGS INC.: PRODUCT SEGMENTS
TABLE 174. TAKARA HOLDINGS INC.: PRODUCT PORTFOLIO
TABLE 175. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
TABLE 176. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
TABLE 177. THERMO FISHER SCIENTIFIC INC.: PRODUCT SEGMENTS
TABLE 178. THERMO FISHER SCIENTIFIC INC.: SERVICE SEGMENTS
TABLE 179. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
TABLE 180. DANAHER CORPORATION: KEY EXECUTIVES
TABLE 181. DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 182. DANAHER CORPORATION: PRODUCT SEGMENTS
TABLE 183. DANAHER CORPORATION: PRODUCT PORTFOLIO
TABLE 184. BGI GENOMICS: KEY EXECUTIVES
TABLE 185. BGI GENOMICS: COMPANY SNAPSHOT
TABLE 186. BGI GENOMICS: SERVICE SEGMENTS
TABLE 187. BGI GENOMICS: PRODUCT PORTFOLIO
TABLE 188. CD GENOMICS: KEY EXECUTIVES
TABLE 189. CD GENOMICS: COMPANY SNAPSHOT
TABLE 190. CD GENOMICS: PRODUCT SEGMENTS
TABLE 191. CD GENOMICS: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. LONG READ SEQUENCING MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF LONG READ SEQUENCING MARKET,2022-2032
FIGURE 03. TOP IMPACTING FACTORS IN LONG READ SEQUENCING MARKET (2022 TO 2032)
FIGURE 04. TOP INVESTMENT POCKETS IN LONG READ SEQUENCING MARKET (2023-2032)
FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
FIGURE 07. MODERATE THREAT OF SUBSTITUTES
FIGURE 08. MODERATE INTENSITY OF RIVALRY
FIGURE 09. MODERATE BARGAINING POWER OF BUYERS
FIGURE 10. GLOBAL LONG READ SEQUENCING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11. LONG READ SEQUENCING MARKET, BY APPLICATION, 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY 2022 AND 2032(%)
FIGURE 14. LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022 AND 2032(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME (SMRT) SEQUENCING, BY COUNTRY 2022 AND 2032(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR NANOPORE SEQUENCING, BY COUNTRY 2022 AND 2032(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR SYNTHETIC LONG READ SEQUENCING, BY COUNTRY 2022 AND 2032(%)
FIGURE 18. LONG READ SEQUENCING MARKET, BY PRODUCT, 2022 AND 2032(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR INSTRUMENTS, BY COUNTRY 2022 AND 2032(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR CONSUMABLES, BY COUNTRY 2022 AND 2032(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR SERVICES, BY COUNTRY 2022 AND 2032(%)
FIGURE 22. LONG READ SEQUENCING MARKET, BY END USER, 2022 AND 2032(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY 2022 AND 2032(%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECH COMPANIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 25. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY 2022 AND 2032(%)
FIGURE 26. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 27. LONG READ SEQUENCING MARKET BY REGION, 2022 AND 2032(%)
FIGURE 28. U.S. LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
FIGURE 29. CANADA LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
FIGURE 30. MEXICO LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
FIGURE 31. GERMANY LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
FIGURE 32. FRANCE LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
FIGURE 33. UK LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
FIGURE 34. ITALY LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
FIGURE 35. SPAIN LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
FIGURE 36. REST OF EUROPE LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
FIGURE 37. JAPAN LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
FIGURE 38. CHINA LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
FIGURE 39. INDIA LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
FIGURE 40. AUSTRALIA LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
FIGURE 41. SOUTH KOREA LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
FIGURE 42. REST OF ASIA-PACIFIC LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
FIGURE 43. BRAZIL LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
FIGURE 44. SAUDI ARABIA LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
FIGURE 45. SOUTH AFRICA LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
FIGURE 46. REST OF LAMEA LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
FIGURE 47. TOP WINNING STRATEGIES, BY YEAR (2020-2024)
FIGURE 48. TOP WINNING STRATEGIES, BY DEVELOPMENT (2020-2024)
FIGURE 49. TOP WINNING STRATEGIES, BY COMPANY (2020-2024)
FIGURE 50. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 51. COMPETITIVE DASHBOARD
FIGURE 52. COMPETITIVE HEATMAP: LONG READ SEQUENCING MARKET
FIGURE 53. TOP PLAYER POSITIONING, 2022
FIGURE 54. AGILENT TECHNOLOGIES, INC.: NET REVENUE, 2021-2023 ($MILLION)
FIGURE 55. AGILENT TECHNOLOGIES, INC.: REVENUE SHARE BY SEGMENT, 2023 (%)
FIGURE 56. AGILENT TECHNOLOGIES, INC.: REVENUE SHARE BY REGION, 2023 (%)
FIGURE 57. ILLUMINA, INC.: NET REVENUE, 2021-2023 ($MILLION)
FIGURE 58. ILLUMINA, INC.: REVENUE SHARE BY SEGMENT, 2023 (%)
FIGURE 59. ILLUMINA, INC.: REVENUE SHARE BY REGION, 2023 (%)
FIGURE 60. PACBIO: NET REVENUE, 2021-2023 ($MILLION)
FIGURE 61. PACBIO: REVENUE SHARE BY REGION, 2023 (%)
FIGURE 62. TAKARA HOLDINGS INC.: SALES REVENUE, 2021-2023 ($MILLION)
FIGURE 63. TAKARA HOLDINGS INC.: REVENUE SHARE BY SEGMENT, 2023 (%)
FIGURE 64. THERMO FISHER SCIENTIFIC INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 65. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 66. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 67. DANAHER CORPORATION: NET SALES, 2020-2022 ($MILLION)
FIGURE 68. DANAHER CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 69. DANAHER CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security